Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT05742256

Oxycodone in Combination With Parathoracic Nerve Block is Used for Postoperative Analgesia in Lung Cancer

Conditions: Oxycodone

Sex: All
Ages: 60 Years – N/A
Phase: PHASE1
Enrollment: 159
Sponsor: Qianfoshan Hospital

Summary

In this study, the effect of oxycodone combined with ultrasound-guided paravertebral nerve block on the postoperative analgesic effect of thoracoscopic lung cancer was investigated, and the effect and reasonable dose of oxycodone were explored, which provided a reference for the clinical multimodal analgesia after thoracoscopic lung cancer surgery.

Eligibility Criteria

Inclusion Criteria:Male or female, age > 60 yearsPatients undergoing thoracoscopic lobectomyASA (American Academy of Anesthesiologists) Grades I-IIIThere were no obvious abnormalities in heart, liver, and kidney functionSign the informed consent form for this clinical studyExclusion Criteria:History of oxycodone or sufentanil allergyRenal or hepatic dysfunctionHistory of drug or alcohol abusePsychiatric disorders: schizophrenia, epilepsy, Parkinson's disease, myasthenia gravisThose who have difficulty communicating due to coma, severe dementia, speech barrier, or those who cannot cooperate due to other diseases.People with head trauma or other brain diseases -

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05742256). StuddyBuddy aggregates publicly available trial information.